Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Opinion CV Team Dispatch

August 2023 News Roundup

L.A. McKeown

August 01, 2023

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2022

Todd Neale

August 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

Caitlin E. Cox

July 04, 2022

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

DOACs Safe, Effective in Subset of Valvular AF Patients

Shelley Wood

March 31, 2021

News Conference News CRT 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

Todd Neale

March 08, 2021

News Conference News AHA 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

Todd Neale

November 14, 2020

Advertisement

What’s Going to Be Hot at TCT 2025

CVD Still the Leading Cause of Death and Disease Globally

April 2025 Dispatch for the CV Team

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

September 2023 News Roundup

August 2023 News Roundup

December 2022 News Roundup

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

TCTMD’s Top 10 Most Popular Stories for July 2022

TCTMD’s Top 10 Most Popular Stories for June 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

December 2021 News Roundup

September 2021 News Roundup

July/August 2021 News Roundup

April 2021 News Roundup

Roughly 80% of ESC Guideline Writers Have Financial COIs

DOACs Safe, Effective in Subset of Valvular AF Patients

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content